Eli Lilly pens Creyon Bio AI oligonucleotide pact with $1B in biobucks on the table – Fierce Biotech
Eli Lilly pens Creyon Bio AI oligonucleotide pact with $1B in biobucks on the table Fierce BiotechWith a new CEO, oligonucleotide biotech Creyon forges Eli Lilly partnership Endpoints NewsEli Lilly (LLY) Partners with Creyon Bio for RNA-Targeted Therap GuruFocusCreyon Bio receives $13M upfront in collaboration with Eli Lilly TipRanksCreyon Bio Appoints Industry Leader, Serge Messerlian as CEO, Leveraging Decades of Company Building and Strategic Collaborations Bluefield Daily Telegraph